Gene modulation

Gene modulation refers to the physiological process or therapeutic methodology used to regulate the expression of specific genes, either by enhancing or suppressing the production of their RNA or protein products [1]. As a therapeutic modality, it encompasses diverse technologies such as CRISPR-Cas9 genome editing, RNA interference (RNAi), antisense oligonucleotides (ASOs), and epigenetic modifiers [2]. Rather than representing a single protein, receptor, or enzyme, gene modulation refers to a suite of interventions aimed at altering the functional output of the genome to treat disease [3]. In clinical applications, these approaches are used to silence overactive oncogenes in cancer, replace missing proteins in monogenic disorders, or inhibit viral replication by targeting viral genetic material [4]. Because the term describes a functional outcome or a technological category rather than a specific physical binding site, it is classified as a therapeutic modality rather than a discrete molecular target [5]. Sources: [1] National Institutes of Health (NIH) - Gene Expression; [2] Nature Reviews Drug Discovery - Evolution of Gene Therapy; [3] Frontiers in Bioengineering and Biotechnology - Recent Advances in Gene Modulation; [4] Cell - The Landscape of Gene-Regulation Technology; [5] FDA - Cellular & Gene Therapy Guidance.

Other names

Gene expression regulationGenetic modulationTranscriptional regulationGene controlGene expression modulation

Modulation of gene expression through various molecular interventions including transcriptional activation, transcriptional repression, post-transcriptional silencing (RNAi), and direct genome editing.